The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Topic summary

Pharmacy supply in the UK and the questions you will be asked

This is a generated summary. It shows the 9 most-liked posts from a topic of 106, in their original order, with the accepted answer included where one exists. It is a reading aid and it will miss nuance — the full topic is the record.
NS
n.serranoTL2 Moderator6 Jan 2026#4

On post #2 — agreed on the reasoning, with one qualification.

Private prescribing is legal and widespread, including through remote consultation. Pharmacies must satisfy themselves that a prescription is clinically appropriate. Expect to be asked for measurements and history.

29 likes 7mo
ST
slow_titratorTL2Regular20 Jan 2026#15

Cross-border arrangements: some people source from other EU countries. Rules on import for personal use are changing post-Brexit. Current status requires checking with UKVI.

29 likes 6mo
DN
d.ndiayeTL2 Moderator7 Feb 2026#33

MHRA is the regulator. Licensed incretin analogues are prescription-only medicines. NHS and private prescribing routes exist with materially different access criteria and costs.

31 likes 6mo
MD
m.duarteTL2 Moderator13 Feb 2026 · edited#40
h.espinoza, post #18: This follows post #15 rather than contradicting it. NHS access has been restricted by commissioning criteria, not by licensing. Specialist weight-management services in many areas require prior weight-loss attempts, BMI thresholds, or other specific criteria. Go to post

Importing for personal use: importing a prescription-only medicine without a prescription is not lawful. Material sold as research-use-only is not a licensed medicine regardless of content.

33 likes in reply to #18 5mo
KK
k.karlsenTL2 Moderator18 Feb 2026#46

Compounding pharmacies: UK allows compounding under specific conditions when a licensed product is unavailable. That is not a front-line option but becomes relevant during shortages.

29 likes 5mo
OF
outline_firstTL3Wiki editor24 Feb 2026#53

MHRA is the regulator. Licensed incretin analogues are prescription-only medicines. NHS and private prescribing routes exist with materially different access criteria and costs.

28 likes 5mo
SC
s.chowdhuryTL3Regular22 Mar 2026#87

Ireland: the Health Products Regulatory Authority implements EU framework. Prescription-only. Reimbursement for weight management has been more restrictive than for diabetes. Private prescription at full cost is usual for weight management.

32 likes 4mo
MD
methods_draftTL2Member30 Mar 2026#97

NHS access has been restricted by commissioning criteria, not by licensing. Specialist weight-management services in many areas require prior weight-loss attempts, BMI thresholds, or other specific criteria.

30 likes 4mo
RN
r.novakTL2 Moderator1 Apr 2026#100
s.lindqvist, post #90: MHRA is the regulator. Licensed incretin analogues are prescription-only medicines. NHS and private prescribing routes exist with materially different access criteria and costs. Go to post

Importing for personal use: importing a prescription-only medicine without a prescription is not lawful. Material sold as research-use-only is not a licensed medicine regardless of content.

32 likes in reply to #90 4mo

Read the full topic (106 posts)

Suggested topics

TopicParticipantsRepliesViewsActivity
UK access routes, dated and sourced
UK access routes, dated and sourced Writing it up because I had to work it out twice and would rather nobody else did. Documenting an access outcome, dated, because everything in this category expires. As of…
NROJC 2 5.8k 15mo
NHS criteria and how they are applied in practice — the long version
Posting this under the heading it deserves: NHS criteria and how they are applied in practice — the long version Everything below is what sits behind that. A coverage question with the paperwork detail…
RLJIWTGBST+11 15 11k 9mo
UK access routes, dated and sourced — a second dataset
Posting this under the heading it deserves: UK access routes, dated and sourced — a second dataset Everything below is what sits behind that. Documenting an access outcome, dated, because everything in this…
EMGBSTYEM+76 82 25k 14mo
MHRA statements, read directly
MHRA statements, read directly Writing it up because I had to work it out twice and would rather nobody else did. A coverage question with the paperwork detail included, since that is what determines the…
VMSOGHTVJ+93 101 2.2k 5mo
NHS criteria and how they are applied in practice
NHS criteria and how they are applied in practice — setting out what I have, and where I think it stops being reliable. A coverage question with the paperwork detail included, since that is what determines…
AEUCRVTPAV+37 42 31k 2d

Related topics — sharing the tags personal import, cost per milligram, MHRA

TopicParticipantsRepliesViewsActivity
About the International category
Country-by-country availability and legality, dated because it changes constantly. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded with its author…
TVDOPMAN+6 11 240 22mo
How compounding permissions changed when supply normalised
Asking directly, because I could not find a straight answer: How compounding permissions changed when supply normalised Structured report rather than an opinion, following the format the maintainers asked…
GCCCCCMEMP+30 34 51k 16mo
Coming back to: Cross-border purchase rules within the EU
Cross-border purchase rules within the EU Writing it up because I had to work it out twice and would rather nobody else did. A coverage question with the paperwork detail included, since that is what…
JEDBNRPFFE+12 16 2.8k 11mo
What changed in 2026, by region
What changed in 2026, by region — that is the question, and I have not found it answered plainly anywhere I have looked. Documenting an access outcome, dated, because everything in this category expires. As…
AFNDCNNNID+110 122 1.4k 18mo
NHS criteria and how they are applied in practice
NHS criteria and how they are applied in practice — setting out what I have, and where I think it stops being reliable. A coverage question with the paperwork detail included, since that is what determines…
AEUCRVTPAV+37 42 31k 2d